DEF 14A

Company

Cellectar Biosciences, Inc.

Filed

August 11, 2017

Period of Report

September 12, 2017

Accession Number

0001144204-17-042239

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →